Selective heterologous regulation of 5-HT1A receptor-stimulated [35S]GTPγS binding in the anterior cingulate cortex as a result of 5-HT2 receptor activation

Brain Research

Volumn 957, Issue 1, 2002, Pages 174-182

  Valdez, M ^a   Burke, T F ^a   Hensler, J G ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

5 HT1A receptor; 5 HT2 receptor; 35S GTP S; 3H ketanserin; DOI; Quantitative autoradiography

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KETANSERIN; RADIOLIGAND; RECEPTOR SUBTYPE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 2 AGONIST; SEROTONIN 2A RECEPTOR;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN CORTEX; CINGULATE GYRUS; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOWN REGULATION; DRUG EFFECT; DRUG RECEPTOR BINDING; LIMBIC CORTEX; MALE; MEDIAN RAPHE NUCLEUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT;

AMPHETAMINES; ANIMALS; AUTORADIOGRAPHY; BRAIN; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GYRUS CINGULI; KETANSERIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SULFUR RADIOISOTOPES;

EID: 0037032607     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03637-5     Document Type: Article

References (48)

1. 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 40:1991;399-412.
2. 2A receptors in the rat medial pre-frontal cortex: an iontophoretic study. Synapse. 17:1994;173-181.
3. 2C receptors, respectively. Neuropsychopharmacology. 13:1995;1-8.
4. Barch D.M., Braver T.S., Akbudak E., Conturo T., Ollinger J., Snyder A. Anterior cingulate cortex and response conflict: effects of response modality and processing domain. Cereb. Cortex. 11:2001;837-848.
5. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
6. Barros D.M., Mello e Souza T., De David T., Choi H., Aguzzoli A., Madche C., Ardenghi P., Medina J.H., Izquierdo I. Simultaneous modulation of retrieval by dopaminergic D1, β-noradrenergic, serotonergic-1A and cholinergic muscarinic receptors in cortical structures of the rat. Behav. Brain Res. 124:2001;1-7.
7. Berg K.A., Maayani S., Clarke W.P. Interactions between effectors linked to serotonin receptors. Ann. N.Y. Acad. Sci. 861:1998;111-120.
8. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:1994;220-226.
9. 2 receptors. Life Sci. 42:1988;2439-2445.
10. 1A binding in rat brain - a combined in situ hybridization/in vitro receptor autoradiographic study. Brain Res. 561:1991;51-60.
11. Christensen A.V., Arnt J., Hyttel J., Larsen J.-J., Svendsen O. Pharmacological effects of a specific dopamine D1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci. 34:1985;1529-1540.
12. Davies M.F., Deisz R.A., Prince D.A., Peroutka S.J. Two distinct effects of 5-hydroxytryptamine on single cortical neurons. Brain Res. 4233:1987;347-352.
13. Duncan J., Owens A.M. Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci. 10:2000;475-483.
14. 1A receptor by phospholipid-derived signaling components. J. Pharmacol. Exp. Ther. 297:2001;1025-1035.
15. Francis P.T., Pangalos M.N., Pearson R.C., Middlemiss D.N., Stratmann G.C., Bowen D.M. 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurons destroyed by intrastriatal volkensin. J. Pharmacol. Exp. Ther. 261:1992;1273-1281.
16. Geary W.A.D., Toga A.W., Wooten G.F. Quantitative film autoradiography for tritium: methodological considerations. Brain Res. 337:1985;99-108.
17. Geary W.A.D., Wooten G.F. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain. J. Pharmacol. Exp. Ther. 225:1983;234-240.
18. 2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken. Mol. Brain Res. 54:1998;199-211.
19. 1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology. 26:2002;565-573.
20. 1A receptors in P11 cells. J. Pharmacol. Exp. Ther. 278:1996;1138-1145.
21. 35S]GTPγS binding as measured by quantitative autoradiography following chronic agonist administration. Br. J. Pharmacol. 132:2001;605-611.
22. 1A receptor regulation: effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology. 4:1991;131-144.
23. Hensler J.G., Truett K.A. The effect of chronic serotonin-2 receptor agonist or antagonist administration on serotonin-1A receptor sensitivity. Neuropsychopharmacology. 19:1998;354-364.
24. Kemp B.E., Pearson R.B. Protein kinase recognition sequence motifs. Trends Biochem. Sci. 15:1990;342-346.
25. Kobilka B.K., Frielle T., Collins S., Yang-Feng T., Kobilka T.S., Francke U., Lefkowitz R.J., Caron M.G. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature. 329:1987;69-75.
26. Kreiss D.S., Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine. J. Pharmacol. Exp. Ther. 274:1995;866-867.
27. 3H]ketanserin binding sites in striatal membranes are associated with a DOPAC release system on dopmainergic nerve endings. Eur. J. Pharmacol. 134:1987;373-375.
28. 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol. Pharmacol. 21:1982;301-314.
29. 1A agonist. J. Pharmacol. Exp. Ther. 279:1996;1035-1042.
30. Liotti M., Mayberg H.S. The role of functional neuroimaging in the neuropsychology of depression. J. Clin. Exp. Neuropsychol. 23:2001;121-136.
31. McGonigle P., Boyson S.J., Reuter S., Molinoff P.B. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. Synapse. 3:1989;74-82.
32. Meller E., Li H., Carr K.D., Hiller J.M. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. J. Pharmacol. Exp. Ther. 292:2000;684-691.
33. Mengod G., Nguyen H., Le H., Waeber C., Lubbert H., Palacios J.M. The distribution and cellular localization of the serotonin1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution. Neuroscience. 35:1990;577-591.
34. 2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res. 524:1990;139-143.
35. 1C receptor is a prominent serotonin receptor subtype in the central nervous system. Proc. Natl. Acad. Sci. USA. 86:1989;6793-6796.
36. Newman M.E., Shapira B., Lerer B. Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonists and antidepressants. J. Pharmacol. Exp. Ther. 260:1992;16-20.
37. Parashos S.A., Barone P., Tucci I., Chase T. Attenuation of D1 antagonist-induced D1 receptor upregulation by concomitant D2 receptor blockade. Life Sci. 41:1987;2279-2284.
38. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
39. Pitman R.K., Shin L.M., Rauch S.L. Investigating the pathogenesis of posttraumatic stress disorder with neuroimaging. J. Clin. Psychiatry. 62:(Suppl. 17):2001;47-54.
40. 1C/2 receptor agonists and antagonists. Eur. J. Pharmacol. 244:1993;1-5.
41. 1A receptor. J. Biol. Chem. 266:1991;14747-14753.
42. Sanders-Bush E., Tsutsumi M., Burris K.D. Serotonin receptors and phosphatidylinositol turnover. Ann. N.Y. Acad. Sci. 600:1990;224-235.
43. Subramaniam S., Lucki I., McGonigle P. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Brain Res. 571:1992;313-322.
44. 2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse. 27:1997;79-82.
45. Witter M.P., Groenewegen H.J., Lopes da Silva F.H., Lohman A. Functional organization of the extrinsic and intrinsic circuitry of the parahippocampal regions. Prog. Neurobiol. 33:1989;161-253.
46. 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351:1995;357-373.
47. Wu J.C., Buchsbaum M., Bunny W.E. Jr. Clinical neurochemical implications of sleep deprivation's effects on the anterior cingulate of depressed responders. Neuropsychopharmacology. 5:(Suppl. 25):2001;S74-S78.
48. 2A receptor activation. J. Neurosci. 21:2001;7919-7927.